Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Thursday, March 31, 2022.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2022 (2022-03-31): -596.04%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-304.94%
RETURN ON EQUITY (ROE) AVG 3Y
-195.97%
RETURN ON EQUITY (ROE) AVG 5Y
-188.99%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$51.99M
Return on Equity (ROE)
N/A
TTM Avg
-304.94%
3Y Avg
-195.97%
5Y Avg
-188.99%
Market Cap
$51.88M
Return on Equity (ROE)
-36.94%
TTM Avg
-31.55%
3Y Avg
-37.51%
5Y Avg
-20.44%
Market Cap
$52.60M
Return on Equity (ROE)
-27.93%
TTM Avg
-11.97%
3Y Avg
0.83%
5Y Avg
3.58%
Market Cap
$51.23M
Return on Equity (ROE)
-278.89%
TTM Avg
-162.92%
3Y Avg
25.71%
5Y Avg
0.37%
Market Cap
$51.19M
Return on Equity (ROE)
-57.10%
TTM Avg
-36.66%
3Y Avg
-227.16%
5Y Avg
-314.45%
Market Cap
$52.83M
Return on Equity (ROE)
N/A
TTM Avg
171.70%
3Y Avg
384.85%
5Y Avg
251.73%
Market Cap
$51.12M
Return on Equity (ROE)
-52.72%
TTM Avg
-32.48%
3Y Avg
-92.81%
5Y Avg
-85.98%
Market Cap
$50.28M
Return on Equity (ROE)
N/A
TTM Avg
-24.59%
3Y Avg
-14.57%
5Y Avg
93.61%
Market Cap
$53.70M
Return on Equity (ROE)
-36114.03%
TTM Avg
-31.09%
3Y Avg
-15.54%
5Y Avg
-12.44%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $51.99M | N/A | -304.94% | -195.97% | -188.99% |
| ImageneBio Inc (IMA)vs › | $51.88M | -36.94% | -31.55% | -37.51% | -20.44% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -27.93% | -11.97% | 0.83% | 3.58% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -278.89% | -162.92% | 25.71% | 0.37% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | -57.10% | -36.66% | -227.16% | -314.45% |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | N/A | 171.70% | 384.85% | 251.73% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -52.72% | -32.48% | -92.81% | -85.98% |
| biote Corp. (BTMD)vs › | $50.28M | N/A | -24.59% | -14.57% | 93.61% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | -36114.03% | -31.09% | -15.54% | -12.44% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -708.48% | 156.13% | 510.26% | 342.91% |
ROE
N/A
ROA
N/A
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2022-03-31 | -596.04% |
| 2021-12-31 | -298.10% |
| 2021-09-30 | -184.14% |
| 2021-06-30 | -141.47% |
| 2020-12-31 | -338.00% |
| 2020-09-30 | -265.84% |
| 2020-06-30 | -228.38% |
| 2020-03-31 | -201.48% |
| 2019-12-31 | -140.49% |
| 2019-09-30 | -117.78% |
| 2019-06-30 | -93.35% |
| 2019-03-31 | -146.69% |
| 2018-12-31 | -109.96% |
| 2017-06-30 | -665.33% |
| 2017-03-31 | -191.20% |
| 2016-12-31 | -209.51% |
| 2016-09-30 | -248.79% |
| 2016-06-30 | -181.29% |
